Table 4.

Gamma analysis results for all patients (n = 40), prostate cohort (n = 20) and greater pelvis cohort (n = 20) for plans on sCT with a derived curve RED_sCT,_mod applied.

	3%/2 mm		2%/2 mm		1%/1 mm
	Pass Rate (%)	Av Gamma	Pass Rate (%)	Av Gamma	Pass Rate (%)	Av Gamma
All Patients	99.8 $\pm$ 0.5	0.14 $\pm$ 0.04	99.6 $\pm$ 0.9	0.2 $\pm$ 0.1	92.9 $\pm$ 5.7	0.4 $\pm$ 0.1
range	100.0–97.5	0.08–0.27	100.0–95.3	0.12–0.37	98.3–71.1	0.24–0.77
Prostate	100.0 $\pm$ 0.1	0.12 $\pm$ 0.02	99.9 $\pm$ 0.1	0.16 $\pm$ 0.03	96.0 $\pm$ 2.0	0.30 $\pm$ 0.08
range	100.0–99.8	0.08–0.16	100.0–99.5	0.12–0.25	98.3–91.1	0.24–0.41
Greater Pelvis	99.6 $\pm$ 0.7	0.16 $\pm$ 0.04	99.2 $\pm$ 1.1	0.22 $\pm$ 0.05	89.8 $\pm$ 6.5	0.44 $\pm$ 0.11
range	100.0–97.5	0.11–0.27	99.9–95.3	0.17–0.37	94.9–71.1	0.33–0.77